My Fit CEO Ai Yamada Selected for 'Forbes 30 Under 30 Asia' Social Impact Category

My Fit CEO Ai Yamada Selected for 'Forbes 30 Under 30 Asia' Social Impact Category

My Fit Co., Ltd., operator of the online menopause clinic platform MYLILY, is pleased to announce that its CEO, Ai Yamada, has been selected for the Social Impact category of 'Forbes 30 Under 30 Asia 2026.'

### About Forbes 30 Under 30 Asia

'Forbes 30 Under 30 Asia' is a list published annually since 2016 by the American business magazine Forbes, recognizing young leaders and innovators under 30 across various fields in the Asia-Pacific region. The Social Impact category recognizes young social entrepreneurs, activists, and change-makers committed to solving social issues and achieving a sustainable society through business and technology.

### Comment from CEO Ai Yamada

'MYLILY was launched with the goal of creating a society where as many women as possible suffering from menopause can access necessary medical care and information. I see this selection as proof that the effort to face health challenges that were once difficult to speak about is indeed needed by society. With gratitude to our users, partner companies, and team members, we will continue to strive toward a society where everyone can live authentically without putting their health on the back burner, under our philosophy of "Changing how we spend our menopause."

### About MYLILY

MYLILY is an insurance-covered online menopause clinic platform. Users can complete everything from booking to prescription via LINE, with consultations from expert female gynecologists available until 10:00 PM, including weekends. Since April 2026, it has evolved into a platform that comprehensively addresses various health challenges for menopausal women, including pre-menopause care, menstrual management, beauty, weight management, and sexual health.

### About My Fit Co., Ltd.

My Fit Co., Ltd. operates under the vision of 'Creating a society that does not put health last.' Focusing on the development and operation of MYLILY, the company provides DX and administrative support to partner medical institutions, aiming to improve the experience of menopause care through the power of technology.